Cargando…

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma

SIMPLE SUMMARY: Synovial sarcoma (SyS) is a rare malignant soft tissue sarcoma bearing the chromosomal translocation t(X;18), which encodes the fusion oncoprotein SS18::SSX. More than 80% of the patients, mainly young in age, are initially diagnosed with localized disease with a 5-year survival rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landuzzi, Lorena, Manara, Maria Cristina, Pazzaglia, Laura, Lollini, Pier-Luigi, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416854/ https://www.ncbi.nlm.nih.gov/pubmed/37568703 http://dx.doi.org/10.3390/cancers15153887

Ejemplares similares

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
por: Guerzoni, Clara, et al.
Publicado: (2014)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
por: Carrabotta, Marianna, et al.
Publicado: (2022)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma
por: Fuchs, Joseph R., et al.
Publicado: (2023)

Metastatic biomarkers in synovial sarcoma
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2017)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017)

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.
por: Nanni, P., et al.
Publicado: (1991)

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
por: Pender, Alexandra, et al.
Publicado: (2018)

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Analysis of mutations in primary and metastatic synovial sarcoma
por: Xing, Zhuo, et al.
Publicado: (2018)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
por: De Giovanni, Carla, et al.
Publicado: (2019)

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
por: De Giovanni, Carla, et al.
Publicado: (2021)

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients
por: Savola, Suvi, et al.
Publicado: (2011)

Clinical and strategic outcomes of metastatic synovial sarcoma on limb
por: Jami, Sayed Abdulla, et al.
Publicado: (2020)

Chemosensitivity of Lung Metastatic High-Grade Synovial Sarcoma
por: Tetta, Cecilia, et al.
Publicado: (2021)

Sarcoid-Like Reactive Lymphadenopathy in Metastatic Synovial Sarcoma
por: Dhillon, Gundip S, et al.
Publicado: (2023)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
por: Mancarella, Caterina, et al.
Publicado: (2020)

miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
por: De Feo, Alessandra, et al.
Publicado: (2022)

IFN-γ and CD38 in Hyperprogressive Cancer Development
por: Angelicola, Stefania, et al.
Publicado: (2021)

Lung Metastatic Nodules as First Presentation of Synovial Cardiac Sarcoma
por: Ampatzidou, F, et al.
Publicado: (2015)

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
por: Landuzzi, Lorena, et al.
Publicado: (2014)

Systemic Treatment for Adults with Synovial Sarcoma
por: Desar, Ingrid M. E., et al.
Publicado: (2018)

Management of locally advanced primary mediastinal synovial sarcoma
por: Chatterjee, Ambarish S, et al.
Publicado: (2017)

Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma
por: Kirkham, Matthew, et al.
Publicado: (2020)

Metastatic pulmonary synovial sarcoma: A double coincidence: Case report
por: Laasri, Khadija, et al.
Publicado: (2022)

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
por: Vlenterie, Myrella, et al.
Publicado: (2016)

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
por: De Giovanni, Carla, et al.
Publicado: (2019)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)

CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2†
por: Sciandra, Marika, et al.
Publicado: (2014)

GI Synovial Sarcomas
por: Sinniah, Rajeev Palar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tom0l9ehlkjn808k5nsuo6r1gd